Medtronic PLC (MDT)
Return on equity (ROE)
| Apr 30, 2025 | Apr 30, 2024 | Apr 26, 2024 | Apr 30, 2023 | Apr 28, 2023 | ||
|---|---|---|---|---|---|---|
| Net income | US$ in thousands | 4,662,000 | 3,676,000 | 3,676,000 | 3,758,000 | 3,758,000 |
| Total stockholders’ equity | US$ in thousands | 48,024,000 | 50,214,000 | 50,214,000 | 51,483,000 | 51,483,000 |
| ROE | 9.71% | 7.32% | 7.32% | 7.30% | 7.30% |
April 30, 2025 calculation
ROE = Net income ÷ Total stockholders’ equity
= $4,662,000K ÷ $48,024,000K
= 9.71%
The return on equity (ROE) for Medtronic PLC has shown a stable trend over the past few years, with slight fluctuations. In April 2023 and April 2024, the ROE stood at 7.30%, indicating the company generated $7.30 in profit for every $100 of shareholders' equity. There was a marginal increase in ROE to 7.32% in both April 2024 and April 2025, suggesting a slight improvement in the company's profitability and efficiency in utilizing shareholders' equity. The significant jump to 9.71% in April 2025 indicates a noteworthy increase in the company's profitability relative to its equity base. Overall, Medtronic PLC's ROE has demonstrated stability and incremental growth, which suggests effective management of resources and a positive performance trend.
Peer comparison
Apr 30, 2025